periostin 在 ECRS 中的作用。
Role of periostin in ECRS.
机构信息
Weihai Municipal Hospital, Weihai, China.
出版信息
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2665-2672. doi: 10.1007/s00405-020-06369-x. Epub 2020 Sep 21.
Abstract
Periostin, an extracelluar matrix protein belonging to the fasciclin family, has been reported to play a key role in the process of Th2-inflammation disease. As eoshinophilic chronic rhinosinusitis has a higher incident rate, studies show that periostin has participated in the process of inflammation and remodeling. This review mainly to summarize researches of periostin in ECRS and to investigate the clinical significance and expression of periostin.
摘要
骨膜蛋白，一种属于纤维粘连蛋白家族的细胞外基质蛋白，据报道在 Th2 炎症性疾病的发生过程中起着关键作用。嗜酸性慢性鼻-鼻窦炎的发病率较高，研究表明骨膜蛋白参与了炎症和重塑过程。本综述主要总结了骨膜蛋白在 ECRS 中的研究，并探讨了骨膜蛋白的临床意义和表达。
相似文献
1
Role of periostin in ECRS.
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2665-2672. doi: 10.1007/s00405-020-06369-x. Epub 2020 Sep 21.
2
Periostin is an aggravating factor and predictive biomarker of eosinophilic chronic rhinosinusitis.
Allergol Int. 2023 Jan;72(1):161-168. doi: 10.1016/j.alit.2022.08.006. Epub 2022 Sep 13.
3
Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with Asthma.
Ann Am Thorac Soc. 2017 May;14(5):667-675. doi: 10.1513/AnnalsATS.201609-720OC.
4
[Clinical significance and expression of periostin in chronic rhinosinusitis with nasal polyps].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 May;34(5):424-427. doi: 10.13201/j.issn.2096-7993.2020.05.009.
5
Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):18-25. doi: 10.1097/ACI.0000000000000496.
6
Residual nasal polyp tissue following dupilumab therapy is associated with periostin-associated fibrosis.
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1807-1817. doi: 10.1007/s00405-023-08336-8. Epub 2023 Nov 18.
7
S100A8 enhances IL-1β production from nasal epithelial cells in eosinophilic chronic rhinosinusitis.
Allergol Int. 2023 Jan;72(1):143-150. doi: 10.1016/j.alit.2022.08.005. Epub 2022 Sep 16.
8
The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps.
Rhinology. 2017 Jun 1;55(2):152-160. doi: 10.4193/Rhino16.314.
9
Periostin as a biomarker in chronic rhinosinusitis: A contemporary systematic review.
Int Forum Allergy Rhinol. 2022 Dec;12(12):1535-1550. doi: 10.1002/alr.23018. Epub 2022 May 30.
10
[Expression and role of IL-33 and its receptor ST2 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Aug;29(15):1350-3, 1371.
引用本文的文献
1
Serum Periostin as a Potential Biomarker in the Evaluation of Allergic Rhinitis: A Pilot Study.
J Asthma Allergy. 2025 Jan 6;18:1-12. doi: 10.2147/JAA.S496020. eCollection 2025.
2
Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice.
World Allergy Organ J. 2024 Feb 15;17(3):100879. doi: 10.1016/j.waojou.2024.100879. eCollection 2024 Mar.
3
Clinical feature-based diagnosis criteria of eosinophil and non-eosinophil chronic rhinosinusitis in Taiwan.
Laryngoscope Investig Otolaryngol. 2023 Oct 11;8(6):1459-1467. doi: 10.1002/lio2.1165. eCollection 2023 Dec.
4
What is new in cancer-associated fibroblast biomarkers?
Cell Commun Signal. 2023 May 4;21(1):96. doi: 10.1186/s12964-023-01125-0.
5
Serum IL-5, POSTN and IL-33 levels in chronic rhinosinusitis with nasal polyposis correlate with clinical severity.
BMC Immunol. 2022 Jun 25;23(1):33. doi: 10.1186/s12865-022-00507-2.
6
The Role of Extracellular Matrix Proteins in Breast Cancer.
J Clin Med. 2022 Feb 25;11(5):1250. doi: 10.3390/jcm11051250.
7
Attenuates Allergic Rhinitis-Induced Inflammation by Inhibiting Periostin Production.
Pharmaceuticals (Basel). 2021 Sep 28;14(10):986. doi: 10.3390/ph14100986.
8
Periostin loss-of-function protects mice from post-traumatic and age-related osteoarthritis.
Arthritis Res Ther. 2021 Apr 8;23(1):104. doi: 10.1186/s13075-021-02477-z.
本文引用的文献
1
Executive summary of EPOS 2020 including integrated care pathways.
Rhinology. 2020 Apr 1;58(2):82-111. doi: 10.4193/Rhin20.601.
2
WITHDRAWN: Glucocorticoids ameliorate periostin-induced tissue remodeling in chronic rhinosinusitis with nasal polyps.
Clin Exp Allergy. 2024 Dec;54(12):1029. doi: 10.1111/cea.13267. Epub 2024 Oct 23.
3
Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps.
Sci Rep. 2018 Jul 30;8(1):11450. doi: 10.1038/s41598-018-29612-2.
4
Diagnostic significance of serum periostin in eosinophilic chronic sinusitis with nasal polyps.
Acta Otolaryngol. 2018 Apr;138(4):387-391. doi: 10.1080/00016489.2017.1388540. Epub 2017 Oct 28.
5
Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis.
Otolaryngol Head Neck Surg. 2018 Jan;158(1):181-186. doi: 10.1177/0194599817737967. Epub 2017 Oct 17.
6
Periostin in Allergic Inflammation.
Allergol Int. 2014;63(2):143-151. doi: 10.2332/allergolint.13-RAI-0663. Epub 2015 Feb 27.
7
Serum periostin, IgE, and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps.
J Allergy Clin Immunol. 2017 Dec;140(6):1705-1708.e3. doi: 10.1016/j.jaci.2017.07.031. Epub 2017 Sep 1.
8
The Role of Periostin in the Occurrence and Progression of Eosinophilic Chronic Sinusitis with Nasal Polyps.
Sci Rep. 2017 Aug 25;7(1):9479. doi: 10.1038/s41598-017-08375-2.
9
Periostin as a marker of mucosal remodelling in chronic rhinosinusitis.
Rhinology. 2017 Sep 1;55(3):234-241. doi: 10.4193/Rhino16.215.
10
Cellular and noncellular bloodborne biomarkers in asthma.
Ann Allergy Asthma Immunol. 2017 Jun;118(6):672-679. doi: 10.1016/j.anai.2017.04.016.
Zotero 插件